Fiber-Rich Nutrition Education for Diabetes and Weight Loss
This study aims to evaluate how a fiber-rich nutrition education program impacts weight in individuals with diabetes.
Full Plate Living Nutrition Education Program
Body Weight+11
+ Diabetes Mellitus
+ Endocrine System Diseases
Treatment Study
Summary
Study start date: January 12, 2026
Actual date on which the first participant was enrolled.This study aims to test how practical and acceptable an 8-session nutrition education program is when introduced in a general internal medicine clinic. The program focuses on teaching participants to follow a diet high in fiber and whole foods, including fruits, vegetables, legumes, whole grains, nuts, and seeds. The goal is to see if such a diet can help manage diabetes better and contribute to weight loss. Understanding the outcomes of this program can lead to improved dietary recommendations for individuals with diabetes or those looking to lose weight. Participants in this study will take part in the nutrition education sessions over a period of about five months. The program will guide them on adopting a diet rich in fiber and whole foods. The main aspect being measured is the change in participants' weight, providing insights into the program’s effectiveness. By assessing the feasibility and acceptability of the program, researchers aim to determine if it can be successfully implemented in a clinical setting.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.48 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 22 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Pre-diabetes or diabetes * Body Mass Index (BMI) 30-42 * UW Health Primary Care Physician Exclusion Criteria: * Pregnant * Active cancer (treatment within one year or planning on having treatment) * Eating Disorder (SDE Screening 2+) * Chronic Kidney Disease (CKD) (Stage 4 or 5) * Patient Health Questionnaire-9 (PHQ9) indicating severe depression (greater than 15) * No PHQ9 and PHQ2 greater than 2 * General Anxiety Disorder-7 (GAD7) indicating severe anxiety (greater than 15) * No GAD 7 and GAD2 greater than 2 * Inflammatory bowel disease (IBD) * Irritable bowel syndrome (IBS) * Readiness to Change less than 7 * Confidence to Change less than 7 * Lack of transportation * Non-English Speaking * No control over food environment * No access to laptop, desktop computer, or tablet * No email or text message access * Unwilling to participate in a shared medical visit * Unable to attend one of the four concurrent shared medical visit session cohorts * For those on insulin, no access to finger-prick blood glucose meter or continuous glucose monitor
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location